Xiang Ling

Principal investigator.

BiotechORCID
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2015First federal award
$2.7MFederal grants as PI5 awards
1Patents grantedLatest Jan 7, 2025
128Papers5,002 citations
Career record

Federal awards and patents by year

20152025
AwardsPatents
Federal awards as principal investigator

5 awards · $2.7M

DateAgencyAwardAmountCompany
Sep 12, 2023NIHSBIR Phase I
Perform non-GLP and GLP TOX/TK studies, and file a novel drug IND with the FDA for advanced pancreatic cancer patient clinical trials
$400KCANGET BIOTEKPHARMA, LLC
Aug 16, 2018NIHSBIR Phase II
A small molecule broad spectrum inhibitor of antiapoptotic genes to treat cancer
$210KCANGET BIOTEKPHARMA, LLC
Aug 14, 2018NIHSBIR Phase I
A novel small molecule FL7N-1 for treating pediatric cancer retinoblastoma
$225KCANGET BIOTEKPHARMA, LLC
Aug 1, 2016NIHSBIR Phase II
A small molecule broad spectrum inhibitor of antiapoptotic genes to treat cancer
$988KCANGET BIOTEKPHARMA, LLC
Sep 2, 2015NIHSBIR Phase II
A small molecule broad spectrum inhibitor of antiapoptotic genes to treat cancer
$903KCANGET BIOTEKPHARMA, LLC
Patents

2 patents as inventor

Matched by the first inventor’s name and the patent’s company.

Among 4,078 researchers in Biotech

Peer ranks

Federal funding#698
Awards as PI#417
Patents#155
From filings, awards and patents

Companies

Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.